TECHNICAL ANALYSIS
HAS
Hasbro
TECHNICAL RATING
TECHNICAL SCORE
90 / 100
Summary
Price sits well above its key averages — about 20.8% above the 20-day, 25.0% above the 50-day and 29.5% above the 200-day moving averages, and the 50/200 crossover is a Golden cross. Momentum is confirming that trend: MACD is above its signal (6.05 vs 3.31) and RSI(14) is 87.6, indicating very strong, though extreme, bullish momentum. The stock has broken above the upper Bollinger band and trading has come with volume above the 20-day average, which supports conviction but also signals heightened volatility. The picture would change if momentum rolls over or the price falls back inside the bands and loses the 50-day support.
Price & Moving Averages
Volume
RSI (14)
MACD (12/26/9)
Formula & Methodology
Short-term trendPrice vs. 20-day moving average (weight 10%)
Intermediate trendPrice vs. 50-day moving average (weight 15%)
Long-term regimePrice vs. 200-day moving average (weight 25%)
Cross state50/200 Golden or Death cross (weight 10%)
Momentum + trendMACD 12/26/9 vs signal line (weight 15%)
Momentum bandsRSI (14) state (weight 10%)
VolatilityBollinger-band position (weight 5%)
ConfirmationVolume vs 20-day average (weight 10%)
Rating ruleFormula: the Technical Score is a weighted composite of eight inputs. Trend inputs — price vs. the 20-day (10%), 50-day (15%), and 200-day (25%) moving averages, and the 50/200 Golden or Death cross state (10%) — carry roughly 60% of the weight. Momentum inputs — MACD (12/26/9) vs. its signal line (15%) and RSI (14) state (10%) — carry 25%. Bollinger-band position (5%) and volume vs. the 20-day average (10%) round out the remainder. Each input contributes +1, 0, or -1, weights are re-normalized when a component is unavailable, and the weighted sum is thresholded at +/-0.45 to Bullish, Neutral, or Bearish.
Data Source
Market data sourced from Tiingo. End-of-day prices and volume power the charts and indicators (MA20/50/200, RSI, MACD, Bollinger Bands, Volume) on this page. This page is informational analysis, not investment advice. See Financial Disclaimer.